title: Successful multitarget therapy using mizoribine and tacrolimus for refractory Takayasu arteritis.
authors.affiliation: Department of Pediatrics, School of Medicine, Institute of Medical Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan. shimizum@staff.kanazawa-u.ac.jp.
authors.forename: Masaki
authors.initials: M
authors.lastname: Shimizu
authors.affiliation: Department of Pediatrics, School of Medicine, Institute of Medical Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Ueno
authors.affiliation: Department of Pediatrics, School of Medicine, Institute of Medical Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Sayaka
authors.initials: S
authors.lastname: Ishikawa
authors.affiliation: Department of Pediatrics, School of Medicine, Institute of Medical Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Tokuhisa
authors.affiliation: Department of Pediatrics, School of Medicine, Institute of Medical Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Natsumi
authors.initials: N
authors.lastname: Inoue
authors.affiliation: Department of Pediatrics, School of Medicine, Institute of Medical Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Akihiro
authors.initials: A
authors.lastname: Yachie
mesh_terms: D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D013625:Takayasu Arteritis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016559:Tacrolimus